Provider review
AquaVita NextGen review
Labels every tier by the supply it buys, and the shortest one is an actual month.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$215/mo sema · $320/mo tirz, labeled one month supply
Visit AquaVita NextGenNo figure is visible from the home page; the prices are inside the shop.
Price as published
AquaVita NextGen
$215/mo sema · $320/mo tirz, labeled one month supply
- Vs median
- $40/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The useful thing about this catalog is the label rather than the number. Each tile states what the price buys as a quantity of time — a one-month supply, a three-month supply — instead of naming a plan and leaving you to work out the billing cycle from context. That sounds minor and is not: a large share of this category prints the word month over four weeks of medication, and a page that says supply rather than plan is describing the thing being shipped rather than the subscription being sold. The shortest tier here is a genuine month. The figures themselves are mid-range, with the dual agonist carrying the usual premium over the single one, and the surrounding catalog is a general injectables shop rather than a GLP-1 specialist. What you should know before going looking is that none of this is visible from the front of the site: the home page carries no figure at all, and the prices are inside the shop. There is also no milligram anywhere, so while the period is unusually clear, the quantity of drug inside that period is not — which leaves you able to budget the month and unable to check whether the month contains the amount you intend to take.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the tier labeled by what it supplies rather than by a plan name
- You want a genuine month rather than a four-week cycle called one
- You want other injectables available from the same shop and account
Look elsewhere if
- You expect prices on the home page. They are inside the shop
- You want to know what a month's supply contains. No milligram is published
- You want a GLP-1 specialist rather than a general injectables catalog
What it actually costs
Price as published
$215/mo sema · $320/mo tirz, labeled one month supply
- Vs median
- $40/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. Each option is labeled by the supply it buys rather than by a plan name, and the shortest is an actual month rather than four weeks, which sounds minor and is not, given how much of this category prints "month" over a four-week cycle. A label that says supply describes what ships rather than what is billed. None of the prices is visible from the home page; they are only in the shop. No milligram is published, so the period is unusually clear and the amount of drug inside it is not. No low-dose product.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Each tier is labeled by the supply it buys, and the shortest is an actual month.
- Both molecules are priced separately with the usual gap between them.
- A returning-patient reorder flow exists separately from the initial intake.
Pharmacy, labs and oversight
AquaVita NextGen does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What AquaVita NextGen publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The useful thing about this catalog is the label rather than the number. Each tile states what the price buys as a quantity of time — a one-month supply, a three-month supply — instead of naming a plan and leaving a reader to work out the billing cycle from context. That sounds minor and is not: a large share of this category prints the word month over four weeks of medication, and a page that says supply rather than plan is describing the thing being shipped rather than the subscription being sold. The shortest tier here is a genuine month. The figures themselves are mid-range, with the dual agonist carrying the usual premium over the single one, and the surrounding catalog is a general injectables shop rather than a GLP-1 specialist. What a reader should know before going looking is that none of this is visible from the front of the site: the home page carries no figure at all, and the prices are inside the shop. There is also no milligram anywhere, so while the period is unusually clear, the quantity of drug inside that period is not — which leaves a reader able to budget the month and unable to check whether the month contains the amount they intend to take.
The honest cons
No price is visible from the home page; the figures are inside the shop.
- No milligram is published, so what a month's supply contains is unstated.
- The GLP-1 line sits inside a general injectables catalog rather than a specialist one.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
AquaVita NextGen is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way AquaVita NextGen does. Both are partners: we may earn a commission if you start care through these links.
Partner
Sesame Care
Wegovy pill from $149/mo + sub
Standard plan, self-directed low dose
Partner
RxSpan MD
$249/mo month to month ($199 on 6-mo)
Standard plan, self-directed low dose
Where this sits
#282 of 548
Ordered with the companies that pay us first, and AquaVita NextGen is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Willow
From $299/mo covering all four formats, none priced separately
- Vs median
- $124/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Willow review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.